Indicators for the total number of melanocytic naevi: An adjunct for screening campaigns. Observational study on 292 patients

British Journal of Dermatology

Volumn 170, Issue 1, 2014, Pages 144-149

  Echeverria B ^a   Bulliard, J L ^b   Guillen C ^a   Nagore, E ^a,c  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER SCREENING; DISEASE MARKER; DISEASE SEVERITY; DYSPLASTIC NEVUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SKIN DEFECT; SPAIN; YOUNG ADULT; AGED; ANALYSIS OF VARIANCE; EARLY DIAGNOSIS; EVALUATION STUDY; MELANOMA; MIDDLE AGED; PATHOLOGY; PIGMENTED NEVUS; PROCEDURES; SENSITIVITY AND SPECIFICITY; SKIN TUMOR;

ADULT; AGED; ANALYSIS OF VARIANCE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 84892393247     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12692     Document Type: Article

References (12)

1. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41: 28-44.
2. Byles JE, Hennrikus D, Sanson-Fisher R, Hersey P,. Reliability of naevus counts in identifying individuals at high risk of malignant melanoma. Br J Dermatol 1994; 130: 51-6.
3. Farinas-Alvarez C, Rodenas JM, Herranz MT, Delgado-Rodríguez M,. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol 1999; 140: 457-62.
4. De Giorgi V, Sestini S, Grazzini M, et al,. Prevalence and distribution of melanocytic naevi on the scalp: a prospective study. Br J Dermatol 2010; 162: 345-9.
5. Augustsson A, Stierner U, Rosdahl I, Suurküla M,. Regional distribution of melanocytic naevi in relation to sun exposure, and site-specific counts predicting total number of naevi. Acta Derm Venereol 1992; 72: 123-7.
6. Stratigos AJ, Forsea AM, van der Leest RJ, et al,. Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future. Br J Dermatol 2012; 167 (Suppl. 2): 99-104.
7. Tucker MA, Greene MH, Clark WH Jr, et al,. Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr 1983; 103: 65-9.
8. Newton Bishop JA, Bataille V, Pinney E, Bishop DT,. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res 1994; 4: 199-206.
9. Bataille V, Bishop JA, Sasieni P, et al,. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. British J Cancer 1996; 73: 1605-11.
10. van der Leest RJ, de Vries E, Bulliard JL, et al,. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol 2011; 25: 1455-65.
11. Newton JA, Bataille V, Griffiths K, et al,. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol 1993; 29: 989-6.
12. Gallus S, Naldi L, Carli P, et al,. Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy. Am J Eidemiol 2007; 166: 472-8.